Evidence that autophosphorylation of solubilized receptors for epidermal growth factor is mediated by intermolecular cross-phosphorylation.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1989-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.86.3.925PMID 2915986PMCID PMC286591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A point mutation at the ATP‐binding site of the EGF‐receptor abolishes signal transduction.

  1988cited by this paper
• Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent.

  1988cited by this paper
• Kinetic parameters of the protein tyrosine kinase activity of EGF‐receptor mutants with individually altered autophosphorylation sites.

  1988cited by this paper
• Molecular analysis of signal transduction by growth factors.

  1988cited by this paper
• Biological activities of EGF‐receptor mutants with individually altered autophosphorylation sites.

  1988cited by this paper
• Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor.

  1987cited by this paper
• A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis

  1987cited by this paper
• Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.

  1987cited by this paper
• Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation.

  1987cited by this paper
• Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding.

  1987cited by this paper
• Allosteric regulation of the epidermal growth factor receptor kinase

  1986cited by this paper
• Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization.

  1986cited by this paper
• Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells.

  1986cited by this paper
• Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor.

  1985cited by this paper
• Protein-tyrosine kinases.

  1985cited by this paper
• Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein.

  1985cited by this paper
• Autophosphorylation sites on the epidermal growth factor receptor

  1984cited by this paper
• Rotational diffusion of epidermal growth factor complexed to cell surface receptors reflects rapid microaggregation and endocytosis of occupied receptors.

  1981cited by this paper
• Epidermal growth factor.

  1979cited by this paper
• Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431

  1979cited by this paper
• Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells.

  1978cited by this paper

• Phaseolus acutifolius Recombinant Lectin Exerts Differential Proapoptotic Activity on EGFR+ and EGFR− Colon Cancer Cells and Provokes T Cell-Assisted Antitumor Responses in Mice

  2025cites this paper
• Reconciling a Kinetic Model for Dimerization of the EGFR Using Single-Molecule Tracking in Living Cells.

  2025cites this paper
• Receptor tyrosine kinases CAD96CA and FGFR1 function as the cell membrane receptors of insect juvenile hormone

  2025cites this paper
• The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

  2024cites this paper
• To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors.

  2023cites this paper
• Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors

  2022cites this paper
• Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward

  2022cites this paper
• Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis

  2021cites this paper
• Allosteric activation of preformed EGF receptor dimers by a single ligand binding event

  2021cites this paper
• Deficiency of GABARAP but Not Its Paralogs Causes Enhanced EGF-Induced EGFR Degradation

  2020cites this paper
• EGFR: An essential receptor tyrosine kinase-regulator of cancer stem cells.

  2020cites this paper
• Goniolanceolatins A-H, Cytotoxic Bis-styryllactones from Goniothalamus lanceolatus.

  2019cites this paper
• Profiling the phosphotyrosine interactome of receptor tyrosine kinases by affinity enrichment-mass spectrometry

  2019cites this paper
• Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion

  2018cites this paper
• structural on the regulation of the epidermal growth factor receptor.

  2018cites this paper
• A Case of Advanced Pulmonary Adenocarcinoma Harboring HER-2 Amplification Treated with Afatinib

  2018cites this paper
• The EGFR odyssey – from activation to destruction in space and time

  2017cites this paper
• HER2 exon 27 mutations predict worse survival of breast cancer patients, especially in HER2‐negative patients

  2017cites this paper
• HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer.

  2017cites this paper
• Quantitative microscopy workflows for the study of cellular receptor trafficking

  2017cites this paper
• Functional and Mechanistic Consequences of Dual Oxidase 1 Suppression in Lung Cancer

  2017cites this paper
• The role of PI3K and ERBB family gene mutations and other abnormalities in resistance to HER2-targeted therapies in HER2-positive breast cancer

  2016cites this paper
• Ligand-dependent responses of the silkworm prothoracicotropic hormone receptor, Torso, are maintained by unusual intermolecular disulfide bridges in the transmembrane region

  2016cites this paper
• High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display

  2016influential citation
• ROLE OF NON-MUSCLE MYOSIN IIB IN BREAST CANCER INVASION

  2016cites this paper
• Oncogenes and Tumor Suppressors Sul fi redoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling

  2015cites this paper
• Rapid evaluation of tyrosine kinase activity of membrane-integrated human epidermal growth factor receptor using the yeast Gγ recruitment system.

  2015cites this paper
• Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases

  2015cites this paper
• Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.

  2015cites this paper
• Some mathematical models of intermolecular autophosphorylation.

  2015cites this paper
• A structural perspective on the regulation of the epidermal growth factor receptor.

  2015cites this paper
• Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling

  2015cites this paper
• Receptor Tyrosine Kinase Signal Transduction and the Molecular Basis of Signalling Specificity

  2015cites this paper
• Receptor Tyrosine Kinases: Structure, Functions and Role in Human Disease

  2015cites this paper
• NUCLEAR TRANSLOCATION OF MET VIA INTERNET MECHANISM

  2014cites this paper
• Transphosphorylation of EGFR at Y845 plays an important role in its autophosphorylation and kinase activity.

  2014cites this paper
• Systematic Analysis of Protein-Protein Interactions Between the ErbB Family of RTKs and a Complete Set of Human Phosphatases

  2014cites this paper
• Cell and molecular biology of epidermal growth factor receptor.

  2014cites this paper
• The EGFR demonstrates linear signal transmission.

  2014cites this paper
• The EGFR family: not so prototypical receptor tyrosine kinases.

  2014cites this paper
• Receptor tyrosine kinases: legacy of the first two decades.

  2014cites this paper
• Coarse-Grained Molecular Simulation of Epidermal Growth Factor Receptor Protein Tyrosine Kinase Multi-Site Self-Phosphorylation

  2014cites this paper
• Intracellular Mechanisms Responsible for Trypsin-induced Increase in Transepithelial Resistance in Intestinal Epithelial Cells

  2013cites this paper
• Signaling by Non-Canonical Receptor Tyrosine Kinases ERBB3 and RYK

  2012cites this paper
• Predicting and testing determinants of histidine-kinase functions by leveraging protein sequence information

  2012cites this paper
• Computational Analysis of Asymmetric Environments of Soluble Epidermal Growth Factor and Application to Single Cell Polarization and Fate Control

  2011cites this paper
• DEFINING THE ROLE OF EGFR ACETYLATION IN CELLULAR PROCESSES: CLINICAL IMPLICATIONS

  2011cites this paper
• TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.

  2011cites this paper
• Characterization of NimA-related Kinase 10 (NEK10): A Role in Checkpoint Control

  2010cites this paper
• BTT-4479-EGFR targeted therapy in non-small cell lung cancer

  2009cites this paper
• Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion.

  2009cites this paper
• Mechanism of the cross talk between growth hormone receptor and epidermal growth factor receptor

  2008cites this paper
• JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin.

  2008cites this paper
• Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.

  2008cites this paper
• Epidermal growth factor receptor family activation and intracellular signaling: Implications for cancer therapeutics

  2008cites this paper
• Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis

  2007cites this paper
• EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR FOR ONCOLOGY: DISCOVERY AND DEVELOPMENT OF ERLOTINIB

  2007cites this paper
• Target validation in drug discovery.

  2007cites this paper
• Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction.

  2006cites this paper
• Signaling through ERBB receptors: multiple layers of diversity and control.

  2006cites this paper
• EGFR Activation Mediates Inhibition of Axon Regeneration by Myelin and Chondroitin Sulfate Proteoglycans

  2005cites this paper
• Yeast growth selection system for detecting activity and inhibition of dimerization-dependent receptor tyrosine kinase.

  2005cites this paper
• Single-molecule measurement in living cells

  2004cites this paper
• Preparation and characterization of Alexa Fluor 594-labeled epidermal growth factor for fluorescence resonance energy transfer studies: application to the epidermal growth factor receptor.

  2004cites this paper
• Analysis of the protein kinase activity of moss phytochrome expressed in fibroblast cell culture

  2004cites this paper
• EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation

  2003cites this paper
• Epidermal growth factor receptor: mechanisms of activation and signalling.

  2003cites this paper
• Epidermal growth factor receptor: mechanisms of activation and signalling.

  2003cites this paper
• Epidermal growth factor stimulates serine/threonine phosphorylation of the focal adhesion protein paxillin in a MEK‐dependent manner in normal rat kidney cells

  2002cites this paper
• Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells*

  2002cites this paper
• Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity

  2002cites this paper
• Activation mechanism of solubilized epidermal growth factor receptor tyrosine kinase.

  2002cites this paper
• Neurotrophic factors for the investigation and treatment of movement disorders

  2001cites this paper
• Cross-talk between the proto-oncogenes Met and Ron

  2000influential citation
• Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane.

  2000cites this paper
• Cell signaling by receptor tyrosine kinases.

  2000cites this paper
• Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells.

  1999cites this paper
• Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice.

  1999cites this paper
• One lyn molecule is sufficient to initiate phosphorylation of aggregated high-affinity IgE receptors.

  1999cites this paper
• Characteristics of EGFR family‐mediated HRG signals in human ovarian cancer

  1999cites this paper
• Prospects for the treatment of endocrine-responsive tumours.

  1999cites this paper
• Growth factor signal transduction and hormone independence in breast cancer

  1999cites this paper
• The level of tyrosine kinase activity regulates the expression of p21/WAF1 in cancer cells.

  1999cites this paper
• Journey beyond immunology. Regulation of receptor internalization by major histocompatibility complex class I (MHC‐I) and effect of peptides derived from MHC‐I

  1998cites this paper
• Prolactin Decreases Epidermal Growth Factor Receptor Kinase Activity via a Phosphorylation-dependent Mechanism*

  1998cites this paper
• Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.

  1998cites this paper
• Membrane fluidity and epidermal growth factor receptor function in breast cancer.

  1998cites this paper
• Induction of tyrosine phosphorylation and association of β-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence

  1997cites this paper
• Self-phosphorylation of epidermal growth factor receptor is an intermolecular reaction.

  1997cites this paper
• Signal transduction through epidermal growth factor receptor is altered in HeLa monolayer cells during mitosis.

  1997cites this paper
• Growth factor receptor tyrosine kinases

  1997cites this paper
• Lateral Mobility of Polypeptide Hormone Receptors and GTP-Binding Proteins

  1997cites this paper
• Evidence for the Role of Immobilization of Ligand-Occupied Membrane Receptors in Signal Transduction

  1997cites this paper
• Requirement for the Adapter Protein GRB2 in EGF Receptor Endocytosis

  1996cites this paper
• The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors.

  1996cites this paper
• Characterization of Dual Leucine Zipper-bearing Kinase, a Mixed Lineage Kinase Present in Synaptic Terminals Whose Phosphorylation State Is Regulated by Membrane Depolarization via Calcineurin*

  1996cites this paper
• Inhibition of demecolcin-induced DNA synthesis by inhibitors of phospholipase C and protein kinase C.

  1996cites this paper
• Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-tyrosine Kinase

  1996cites this paper
• Transforming potentials of epidermal growth factor and nerve growth factor receptors inversely correlate with their phospholipase C gamma affinity and signal activation.

  1996cites this paper
• A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.

  1996cites this paper